Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 3/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.31 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5009630 | 1.00 | CYP1A2 (0.36) | CYP1A2CYP2C19KMT2ALMNATDP1 | |
| SCHEMBL5007593 | 0.83 | F2 (0.39) | CYP1A2CYP2C19KMT2ALMNATDP1 | |
| SCHEMBL5007599 | 0.83 | F2 (0.39) | CYP1A2CYP2C19KMT2ALMNATDP1 | |
| SCHEMBL5007590 | 0.81 | F2 (0.40) | CYP1A2CYP2C19KMT2ALMNATDP1 | |
| SCHEMBL2428796 | 0.78 | CYP1A2 (0.40) | CYP1A2CYP2C19KMT2ALMNATDP1 | |
| SCHEMBL13994242 | 0.75 | CYP3A4 (0.38) | CYP1A2CYP2C19KMT2ALMNATDP1 | |
| SCHEMBL13082284 | 0.73 | CYP1A2 (0.44) | CYP1A2CYP2C19KMT2ALMNASLC22A12 | |
| SCHEMBL4972108 | 0.72 | CYP1A2 (0.43) | CYP1A2CYP2C19KMT2ASLC22A12KDM4E | |
| SCHEMBL2431935 | 0.72 | CYP1A2 (0.43) | CYP1A2CYP2C19KMT2AKDM4EPOLB | |
| SCHEMBL5011622 | 0.71 | LMNA (0.45) | CYP1A2CYP2C19LMNASLC22A12KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080300280-A1 | Cyanobenzene Compounds for Combating Animal Pests | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300280-A1 | Cyanobenzene Compounds for Combating Animal Pests | NR0B1, NR0B2, CBR1 | CYP1A2 149/4885CYP2C19 960/4885KMT2A 2706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.